Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Hodge

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Diabetes, Obesity & Metabolism|January 29, 2016
Therapeutic potential of Takeda-G-protein-receptor-5 (TGR5) agonists. Hope or hype?R J Hodge, D J Nunez
Behavioral and Neural Biology|March 1, 1981
Engram duplication in the day-old chickR J Hodge, M E Gibbs, K T Ng
Journal of the American Veterinary Medical Association|April 1, 1986
Near circumferential retroperitoneal rectal tear in a ponyR M Embertson, R J Hodge, A M Vachon
Behavioral and Neural Biology|March 1, 1981
Sequences in duplication of unilateral memory in monocular learningR J Hodge, M E Gibbs, K T Ng
Behavioural Brain Research|February 1, 1984
Effects of hypoxia on memory consolidation: implications for a multistage model of memoryC Allweis, M E Gibbs, K T Ng, et al.
Brain Research Bulletin|July 1, 1983
Inhibition of long-term memory formation in the chicken by anti chick Thy-1 antibodyC C Bernard, M E Gibbs, R J Hodge, et al.
Diabetes, Obesity & Metabolism|July 17, 2015
GSK2374697, a long duration glucagon-like peptide-1 (GLP-1) receptor agonist, reduces postprandial circulating endogenous total GLP-1 and peptide YY in healthy subjectsJ Lin, R J Hodge, R L O'Connor-Semmes, et al.
Clinical Pharmacology and Therapeutics|September 20, 2014
GSK2374697, a novel albumin-binding domain antibody (AlbudAb), extends systemic exposure of exendin-4: first study in humans--PK/PD and safetyR L O'Connor-Semmes, J Lin, R J Hodge, et al.
Diabetes, Obesity & Metabolism|February 4, 2009
Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in healthy subjectsM A Bush, J E Matthews, E H De Boever, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Diabetes, Obesity & Metabolism|January 29, 2016
Therapeutic potential of Takeda-G-protein-receptor-5 (TGR5) agonists. Hope or hype?R J Hodge, D J Nunez
Behavioral and Neural Biology|March 1, 1981
Engram duplication in the day-old chickR J Hodge, M E Gibbs, K T Ng
Journal of the American Veterinary Medical Association|April 1, 1986
Near circumferential retroperitoneal rectal tear in a ponyR M Embertson, R J Hodge, A M Vachon
Behavioral and Neural Biology|March 1, 1981
Sequences in duplication of unilateral memory in monocular learningR J Hodge, M E Gibbs, K T Ng
Behavioural Brain Research|February 1, 1984
Effects of hypoxia on memory consolidation: implications for a multistage model of memoryC Allweis, M E Gibbs, K T Ng, et al.
Brain Research Bulletin|July 1, 1983
Inhibition of long-term memory formation in the chicken by anti chick Thy-1 antibodyC C Bernard, M E Gibbs, R J Hodge, et al.
Diabetes, Obesity & Metabolism|July 17, 2015
GSK2374697, a long duration glucagon-like peptide-1 (GLP-1) receptor agonist, reduces postprandial circulating endogenous total GLP-1 and peptide YY in healthy subjectsJ Lin, R J Hodge, R L O'Connor-Semmes, et al.
Clinical Pharmacology and Therapeutics|September 20, 2014
GSK2374697, a novel albumin-binding domain antibody (AlbudAb), extends systemic exposure of exendin-4: first study in humans--PK/PD and safetyR L O'Connor-Semmes, J Lin, R J Hodge, et al.
Diabetes, Obesity & Metabolism|February 4, 2009
Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in healthy subjectsM A Bush, J E Matthews, E H De Boever, et al.
Pageof 1